The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 The small animal imaging (in-vivo) market has witnessed remarkable growth, evolving from $2.59 billion in 2023 to a projected $2.91 billion in 2024 at an impressive CAGR of 12.6%. Projections indicate continued expansion, with an estimated market size of $4.55 billion by 2028, boasting a CAGR of 11.8%. What fuels this growth, and what trends and technologies are steering the market forward?

Rapid Growth Catalysts in Recent Years

• Preclinical Research and Drug Development: The market’s historical growth was fueled by a surge in preclinical research and drug development activities.
• Pharmaceutical and Biotechnology Sectors Expansion: The market benefited from the expanding pharmaceutical and biotechnology sectors.
• Translational Research and Disease Modeling: The growth was further driven by increased focus on translational research, disease modeling, and pathophysiology studies.
• Academic and Government Funding: Robust support from academic institutions and government funding for research played a crucial role in market expansion.

Forecasts and Emerging Trends

• Development of Novel Imaging Probes: Anticipated growth in the forecast period can be attributed to the development of novel imaging probes and tracers.
• Expansion of Preclinical CROs: The integration of Contract Research Organizations (CROs) into preclinical research contributes significantly to market expansion.
• Integration of AI in Image Analysis: The incorporation of Artificial Intelligence (AI) in image analysis is a key trend, enhancing efficiency and accuracy.
• Advanced Multimodal Imaging Systems: The adoption of advanced multimodal imaging systems contributes to more comprehensive and insightful data collection.
• 3D and High-Resolution Imaging: The market is witnessing a surge in demand for 3D and high-resolution imaging for small animals.

Key Trends Shaping the Forecast Period

• Molecular and Functional Imaging: The forecast period sees a significant focus on molecular and functional imaging in small animals.
• Longitudinal and Real-Time In-Vivo Imaging: Researchers are increasingly turning to longitudinal and real-time in-vivo imaging techniques.
• Hybrid Imaging Modalities: Integration of hybrid imaging modalities provides a wealth of multimodal information.
• CRISPR-Edited Animal Imaging: Researchers are utilizing imaging techniques for studying CRISPR-edited animals, facilitating genetics research.
• AI-Driven Phenotyping and Biomarker Discovery: Artificial intelligence is playing a pivotal role in phenotyping and biomarker discovery.
• Imaging for Neurodegenerative Diseases: There is a growing emphasis on utilizing imaging for research related to neurodegenerative diseases and neuroscience.

Chronic Diseases as Growth Drivers

• Elevated Incidence: The surge in chronic diseases, projected to increase by 99.5% among individuals aged 50 and older by 2050, is a significant driver.
• Role of Small Animal Imaging Techniques: Micro-CT, micro-MRI, and micro-PET play a crucial role in preclinical research, aiding in understanding disease mechanisms and testing novel therapies.
• Market Growth Implication: The rise in chronic diseases is expected to propel the small animal imaging (in-vivo) market forward.

Major Players and Market Segmentation

• Key Companies: Leading companies in the market include Bruker Corporation, PerkinElmer Inc., Miltenyi Biotec GmbH, Siemens AG, and others.
• Market Segmentation:
  • By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components.
  • By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics.
  • By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers.

View More On The Small Animal Imaging (In-Vivo) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Technological Advancements Fueling Growth

• Automated Advanced Technology Ultrasound: PerkinElmer’s Vega imaging system, launched in April 2022, exemplifies the market’s focus on advanced technology.
• Rigaku Corporation’s Strategic Acquisition: Rigaku Corporation’s acquisition of MILabs B.V. in August 2021 exemplifies strategic moves to expand life sciences modality business.

Regional Dynamics

• North America Leading: North America emerged as the largest region in the small animal imaging (in-vivo) market in 2023.
• Europe’s Growth Prospects: Europe is anticipated to be the fastest-growing region in the forecast period.

Conclusion: A Dynamic Future Awaits
The small animal imaging (in-vivo) market is on an upward trajectory, driven by factors such as technological advancements, increased research in chronic diseases, and innovative imaging modalities. As the market continues to evolve, it promises a dynamic future, marked by transformative technologies and a deeper understanding of preclinical research and disease mechanisms. Researchers, industry players, and investors alike are poised to benefit from the vibrant landscape that the small animal imaging market presents.

Request A Sample Of The Global Small Animal Imaging (In-Vivo) Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=7303&type=smp